Dentium

145720 · KOSPI · Health Care · SMALL CAP

Provisional Q2 2026 results.

Dentium filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$63.3M (+8.6% year on year), operating profit of US$10.4M (−5.5% year on year) and net income of US$9.84M (+193.5% year on year).

Earnings(Operating results (consolidated) (preliminary) (fair disclosure))· FILED 2026-08-11· RCEPT 20260811800486

US$63.3MRevenue
+8.6%Revenue vs a year earlier
US$10.4MOperating profit

Converted at 1 USD ≈ ₩1,412.18 (filing-date rate, 2026-08-11 close)

What happened

Dentium filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$63.3M (+8.6% year on year), operating profit of US$10.4M (−5.5% year on year) and net income of US$9.84M (+193.5% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$63.3M
Revenue vs a year earlier+8.6%
Operating profitUS$10.4M
Net incomeUS$9.84M
PeriodQ2 2026 (consolidated)
Filed2026-08-11, Operating results (consolidated) (preliminary) (fair disclosure)
SourceDART rcept 20260811800486 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-08-11 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.